Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Erythrocytosis and thrombocytosis secondary to hyperandrogenism caused by ovarian Leydig cell tumor (CROSBI ID 293139)

Prilog u časopisu | stručni rad | međunarodna recenzija

Mirošević, Gorana ; Butorac, Dražan ; Kruljac, Ivan ; Vrkljan, Milan Erythrocytosis and thrombocytosis secondary to hyperandrogenism caused by ovarian Leydig cell tumor // Endocrine oncology and metabolism, 3 (2017), 4; 124-126. doi: 10.21040/eom/2017.3.4.6

Podaci o odgovornosti

Mirošević, Gorana ; Butorac, Dražan ; Kruljac, Ivan ; Vrkljan, Milan

engleski

Erythrocytosis and thrombocytosis secondary to hyperandrogenism caused by ovarian Leydig cell tumor

Both erytroblasts and megakaryocytes contain androgen receptors, and testosterone regulates their expression. However, the exact mechanisms of testosterone's hematopoietic effects are poorly understood. We report a case of perimenopausal woman with severe hyperandrogenism caused by pure Leydig cell ovarian tumor accompanied by concomitant erythrocytosis and thrombocytosis. Substantial, immediate, and persistent decrease in both red blood cell count and platelet count after testosterone-secreting tumor removal in our patient suggests testosterone's synergistic effect on erythropoiesis and thrombopoiesis.

testosterone, hematopoesis, erytrocytosis, trombocytosis, Leydig cell tumor

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

3 (4)

2017.

124-126

objavljeno

1849-8922

1849-9031

10.21040/eom/2017.3.4.6

Povezanost rada

Kliničke medicinske znanosti

Poveznice